Cargando…
PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429540/ http://dx.doi.org/10.1097/01.HS9.0000975300.66917.8b |
| _version_ | 1785090740236320768 |
|---|---|
| author | Strassl, Irene Machherndl-Spandl, Sigrid Buxhofer-Ausch, Veronika Binder, Michaela Stiefel, Olga Milanov, Robert Kaynak, Emine Girschikofsky, Michael Petzer, Andreas Clausen, Johannes |
| author_facet | Strassl, Irene Machherndl-Spandl, Sigrid Buxhofer-Ausch, Veronika Binder, Michaela Stiefel, Olga Milanov, Robert Kaynak, Emine Girschikofsky, Michael Petzer, Andreas Clausen, Johannes |
| author_sort | Strassl, Irene |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10429540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104295402023-08-17 PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE Strassl, Irene Machherndl-Spandl, Sigrid Buxhofer-Ausch, Veronika Binder, Michaela Stiefel, Olga Milanov, Robert Kaynak, Emine Girschikofsky, Michael Petzer, Andreas Clausen, Johannes Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429540/ http://dx.doi.org/10.1097/01.HS9.0000975300.66917.8b Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Strassl, Irene Machherndl-Spandl, Sigrid Buxhofer-Ausch, Veronika Binder, Michaela Stiefel, Olga Milanov, Robert Kaynak, Emine Girschikofsky, Michael Petzer, Andreas Clausen, Johannes PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title_full | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title_fullStr | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title_full_unstemmed | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title_short | PB2134: BCMA-TARGETED THERAPIES IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA AFTER ALLOGENEIC STEM CELL TRANSPLANTATION – A SINGLE CENTER EXPERIENCE |
| title_sort | pb2134: bcma-targeted therapies in patients with relapsed/refractory multiple myeloma after allogeneic stem cell transplantation – a single center experience |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429540/ http://dx.doi.org/10.1097/01.HS9.0000975300.66917.8b |
| work_keys_str_mv | AT strasslirene pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT machherndlspandlsigrid pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT buxhoferauschveronika pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT bindermichaela pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT stiefelolga pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT milanovrobert pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT kaynakemine pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT girschikofskymichael pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT petzerandreas pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience AT clausenjohannes pb2134bcmatargetedtherapiesinpatientswithrelapsedrefractorymultiplemyelomaafterallogeneicstemcelltransplantationasinglecenterexperience |